期刊文献+

15-PGDH诱导药物对人乳腺癌MCF-7细胞的生长抑制作用及其机制研究

Inhibitory Effect of 15-PGDH Induction Drugs on Growth of Human Breast Cancer MCF-7 Cells and Its Mechanism
下载PDF
导出
摘要 目的探讨15-羟前列腺素脱氢酶(15-PGDH)诱导药物对人乳腺癌MCF-7细胞的生长抑制作用及其机制。方法采用MTT法测定4种非特异性15-PGDH诱导药物--布洛芬(IBU)、吲哚美辛(IND)、吡格列酮(PIO)、地塞米松(DXM)对MCF-7细胞增殖的影响;Hoechst 33258检测细胞凋亡情况;Western blotting检测15-PGDH、COX-2蛋白表达水平;ELISA法检测细胞上清液中PGE2水平。结果低毒浓度(IBU 200μmol·L^-1,IND 100μmol·L^-1,PIO 20μmol·L^-1,DXM 100 nmol·L^-1)下,4种15-PGDH诱导药物联合用药可协同增强阿霉素(ADM)、紫杉醇(TAXOL)对MCF-7细胞的生长抑制作用和凋亡诱导作用;4种15-PGDH诱导药物干预后,均可降低MCF-7细胞中COX-2蛋白表达水平和细胞上清液中PGE2水平,IBU可显著降低15-PGDH蛋白表达水平,而IND、PIO和DXM对15-PGDH蛋白表达无显著影响。结论15-PGDH诱导药物可增强ADM、TAXOL对MCF-7细胞的生长抑制作用和凋亡诱导作用,其机制可能与抑制COX-2表达、降低PGE2水平有关。 Objective To explore the inhibitory effect of 15-hydroxyprostaglandin dehydrogenase(15-PGDH)induction drugs on the groMh of human breast cancer MCF-7 cells and its mechanism.Methods Inhibitory effect of 15-PG DH induction drugs including ibuprofen(IBU),indomethacin(IND),pioglitazone(PIO)and dexamethasone(DXM)on breast cancer MCF-7 cells were assayed by MTT method.Cell apoptosis was detected by Hoechst 33258 stain assay.The 15-PGDH and COX-2 protein expressions in MCF-7 cells were detected by Western blotting.The prostaglandin E2(PGE2)levels in supernatant of cells were determined by ELISA assay.Results The four 15-PGDH induction drugs(IBU 200μmol·L^-1,IND 100μmol·L^-1,PIO 20μmol·L^-1,DXM 100 nmol·L^-1)enhanced the effects of proliferation-inhibition and apoptosis-induction when combined with doxorubicin(ADM)and paclitaxel(TAXOL)in MCF-7 cells.The expression of COX-2 protein and the level of PGE2 in the supernatant of MCF-7 cells were decreased after intenvention of the four 15-PGDH induction drugs.IBU could significantly reduce the expression of 15-PGDH protein,while the other three induction drugs had no effects on it.Conclusion 15-PGDH induction drugs could enhance the growth-inhibiting and apoptosis-inducing effects of ADM and TAXOL on MCF-7 cells.The mechanism might be related to the inhibition of COX-2 protein expression and the decrease of PGE2 level.
作者 欧阳林旗 魏凤 王胜峰 OUYANG Linqi;WEI Feng;WANG Shengfeng(Department of Pharmacy,First Affiliated Hospital of Hunan University of Chinese Medicine,Changsha,Hunan,410007,China;Department of Pharmacy,the Third Xiangya Hospital of Central South University,Changsha,Hunan,Hunan,410013,China)
出处 《肿瘤药学》 CAS 2020年第1期27-33,共7页 Anti-Tumor Pharmacy
关键词 15-PGDH COX-2 15-PGDH诱导药物 细胞增殖 细胞凋亡 PGE2 乳腺癌 15-PGDH COX-2 15-PGDH induction drug Cell growth Cell apoptosis PGE2 Breast cancer
  • 相关文献

参考文献6

二级参考文献27

  • 1左朝晖,黎祖荣,周晓,欧阳永忠,周征宇,曾亮.环氧合酶-2抑制剂塞来昔布对人肝癌HepG2裸小鼠移植瘤生长和肿瘤血管生成的抑制作用[J].癌症,2006,25(4):414-420. 被引量:25
  • 2Lumachi F, Brunello A, Maruzzo M, et al. Treatment of estrogenreceptor-positive breast cancer [ J ]. Curr Med Chem, 2013 , 20(5):596 -604.
  • 3Kamangar F, Dores G M, Anderson W F. Patterns of cancer inci-dence ,mortality, and prevalence across five continents : definingpriorities to reduce cancer disparities in different geographic re-gions of the world[ J]. J Clin Oncol,2006,24( 14) :2137 -50.
  • 4Steele N, Zekri J, Coleman R, et al. Exemestane in metastaticbreast cancer : effective therapy after third-generation non-steroidalaromatase inhibitor failure[ J] . Breast,2006,15(3) :430 -6.
  • 5Sui H, Zhu H R, Wu J, et al. Effects of Jianpi Jiedu Recipe(JJR) on reversion of P-glycoprotein-mediated multidrug resist-ance through COX-2 pathway in colorectal cancer[ J ]. Chin J Inte-gr Med ,2013 : [ Epub ahead of print].
  • 6Lipton A, Campbell-Baird C, Witters L, et al. Phase II trial ofgemcitabine, irinotecan, and celecoxib in patients with advancedpancreatic cancer[ J] . J Clin Gastroenterol, 2010,44 (4 ) :286-8.
  • 7Mello S B, Barros D M,Silva A S,et al. Methotrexate as a prefer-ential cyclooxygenase 2 inhibitor in whole blood of patients withrheumatoid arthritis [ J ]. Rheumatology ( Oxford ),2000,39 ( 5 ):533 -6.
  • 8Herman S,Zurgil N, Deutsch M. Low dose methotrexate inducesapoptosis with reactive oxygen species involvement in T lymphocyt-ic cell lines to a greater extentthan in monocytic lines [ J] . InilammRes,2005,54(7) :273 - 80.
  • 9Mihara M, Urakawa K, Takagi N,et al. In vitro and in vivo biolog-ical activities of a novel nonpolyglutamable anti-folate, MX-68[J]. Immunopharmacology,1996,35(1) :41 -6.
  • 10Mariani F, Sena P, Marzona L,et al. Cyclooxygenase-2 and hy-poxia-inducible factor-1 alpha protein expression is related to in-Aammation,and up-regulated since the early steps of colorectal car-cinogenesis[ J]. Cancer Lett, 2009,279(2):221 -9.

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部